Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Peter Kolchinsky, RA Capital Up Stake in Achillion Pharmaceuticals Even Higher

Peter Kolchinsky, Achillion Pharmaceuticals: This afternoon, Peter Kolchinsky and his hedge fund, RA Capital Management, strengthened their position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), a Form 4 filing with the SEC showed. RA Capital bought a total of some 2.4 million shares of the company via eight transactions at an average price of approximately $2.80 apiece. Following the acquisition of additional shares, RA now owns almost 19.3 million shares of Achillion.

Peter Kolchinsky

Disclosure: none

Recommended Reading:

Billionaire Ron Burkle Urges Morgans Hotel Group to Sell Itself…Again

Which Phone Warren Buffett Used In 2008 Could Have Changed History…But Probably Not

Ridgeback Capital Follows Steven Cohen Into Arrowhead Research

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.